Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluviral (2009-2010) Immunogenicity and Safety in Adults and Elderly
NCT00929331Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2009
- Primary completion
- Aug 2009
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (formaldehyde inactivated) in influenza, sponsored by GSK. Started Jul 2009; status: completed.
02
Drugs
influenza A virus A/California/7/2009 X-179A (H1N1) hemagglutinin antigen (formaldehyde inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00929331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00929331.